This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • IMMORTAL
      • Kidney Cancer
        • RadiCal
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • ECLIPSE
        • FORT
        • NRG-GU 0101
        • Masofaniten (Oral EPI-7386)
        • RTIRE
        • SHORTER
        • SPLASH
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Endourology
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • AMA Interim 2023
      • SUO 2023
      • ESMO 2023
      • IBCN 2023
      • ASTRO 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
Berberine suppresses androgen receptor signaling in prostate cancer - Abstract June 14, 2011
Identification of the prostate cancer index lesion by real-time elastography: Considerations for focal therapy of prostate cancer - Abstract June 14, 2011
Editor's Commentary - Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: A retrospective study June 14, 2011
SUFU 2011 - Management of GU strictures after treatment of prostatic disease - Session Highlights June 14, 2011
Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model - Abstract June 13, 2011
High intensity focused ultrasound in clinical tumor ablation - Abstract June 13, 2011
Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy - Abstract June 13, 2011
Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment - Abstract June 13, 2011
Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: Findings at radical prostatectomy - Abstract June 13, 2011
Immunotherapy for the treatment of prostate cancer - Abstract June 13, 2011
Physical Activity after Diagnosis and Risk of Prostate Cancer Progression: Data from the Cancer of the Prostate Strategic Urologic Research Endeavor - Abstract June 13, 2011
Between-method differences in prostate-specific antigen assays affect prostate cancer risk prediction by nomograms - Abstract June 13, 2011
Tracer kinetic model selection for dynamic contrast-enhanced computed tomography imaging of prostate cancer - Abstract June 13, 2011
AUA 2011 - Effect of long-acting testosterone injections for treatment of hypogonadism after brachytherapy for prostate cancer - Session Highlight by Doron S. Stember, MD June 13, 2011
Picking the optimal treatment for patients with metastatic castration resistant prostate cancer - Slide Presentation June 13, 2011
Abiraterone and increased survival in metastatic prostate cancer - Abstract June 12, 2011
A short-term cost-effectiveness study comparing robot-assisted laparoscopic and open retropubic radical prostatectomy - Abstract June 11, 2011
The contemporary concept of significant versus insignificant prostate cancer - Abstract June 10, 2011
A population-based study of prostate cancer chemotherapy - Abstract June 10, 2011
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21 - Abstract June 10, 2011
Page 1301 of 1350
  • Start
  • Prev
  • 1296
  • 1297
  • 1298
  • 1299
  • 1300
  • 1301
  • 1302
  • 1303
  • 1304
  • 1305
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free